In the BioHarmony Drug Report Database
Phenprocoumon
Liquamar (phenprocoumon) is a small molecule pharmaceutical. Phenprocoumon was first approved as Liquamar on 1982-01-01. It is used to treat pulmonary embolism, thromboembolism, and venous thrombosis in the USA. The pharmaceutical is active against vitamin K epoxide reductase complex subunit 1.
Trade Name
|
Liquamar |
|---|---|
Common Name
|
phenprocoumon |
ChEMBL ID
|
CHEMBL1465 |
Indication
|
pulmonary embolism, thromboembolism, venous thrombosis |
Drug Class
|
Image (chem structure or protein)